Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14051 |
5-Hydroxylansoprazole
AG1908 |
Proton pump | Membrane transporter/Ion channel |
5-Hydroxylansoprazole (AG1908) is an active metabolite of Lansoprazole, a gastric proton-pump inhibitor that effectively treats various peptic diseases[1][2]. The metabolism of Lansoprazole occurs through CYP2C19, resulting in the formation of 5-Hydroxylansoprazole. | |||
T23586 |
5-Hydroxylansoprazole sulfone
AG1909,AG 1909,AG-1909 |
||
5-hydroxylansoprazole is an in vitro metabolism-dependent CYP2C19 inhibitor. |